Taking estrogen affects nearly every major system in your body, from your bones and skin to your brain chemistry and metabolism. Whether prescribed for menopause symptoms, gender-affirming care, or other hormonal conditions, estrogen works by binding to receptors found in tissues throughout the body and switching specific genes on or off. The effects range from rapid relief of hot flashes (often within a month) to slower changes in bone density, body composition, and cholesterol that develop over months to years.
How Estrogen Works in Your Body
Estrogen doesn’t do just one thing because it doesn’t act in just one place. Your body has two main types of estrogen receptors, and they’re distributed across different tissues. One type is concentrated in the uterus, breast, liver, and ovaries. The other is more active in bone marrow, the brain, and parts of the reproductive system. When estrogen reaches a cell that has these receptors, it triggers them to enter the nucleus and directly influence which genes get turned on or off.
This is why estrogen’s effects are so wide-ranging. The same hormone produces different results depending on which tissue it reaches and which receptor type is present. It’s also why the effects of taking estrogen unfold on different timelines: some changes happen within weeks, while others take years to fully develop.
Hot Flashes and Menopause Symptoms
For people going through menopause, relief from hot flashes and night sweats is often the primary reason for starting estrogen. It’s also one of the fastest effects. Estrogen therapy reduces both the frequency and intensity of vasomotor symptoms by roughly 90%, and most people notice improvement within the first month. This makes it the most effective available treatment for the sudden waves of heat, sweating, and sleep disruption that affect up to 80% of menopausal women.
Vaginal dryness, another common menopause symptom, also responds well to estrogen, though it can take a bit longer to fully resolve. Low-dose vaginal estrogen is sometimes prescribed specifically for this without the broader systemic effects of oral or patch forms.
Skin, Collagen, and Elasticity
Estrogen has a surprisingly large role in skin health. It directly influences the cells that produce collagen, maintain skin thickness, and retain moisture. After menopause, when estrogen levels drop sharply, skin loses about 1.5% of its elasticity per year. Women on hormone therapy don’t show this same decline.
Taking estrogen increases the water content of your skin, boosts collagen production, and improves the structure of elastic fibers in the deeper layers. It also speeds up wound healing. Skin thickness actually fluctuates with estrogen levels even during a normal menstrual cycle, reaching its lowest point when estrogen is at its lowest. Replacing estrogen after menopause has been shown to increase skin thickness, reduce wrinkle depth, and improve overall firmness.
Bone Density and Fracture Risk
Estrogen is one of the key signals that tells your bones to maintain their density. When estrogen drops after menopause, bone breakdown accelerates faster than new bone can form, which is why osteoporosis rates climb sharply in postmenopausal women.
Taking estrogen reverses this pattern. In studies of transdermal estrogen (delivered through a skin patch), bone mineral density in the lumbar spine increased by 3.4% after one year and 3.7% after two years. These numbers may sound modest, but in the context of bone health, they represent a meaningful shift from losing bone to actively building it. Estrogen therapy successfully protects bone structure and reduces fracture risk in older women.
Cholesterol and Heart Health
Oral estrogen produces notable changes in your cholesterol profile. In clinical studies, it lowered LDL (“bad”) cholesterol by 14 to 19% and raised HDL (“good”) cholesterol by 15 to 18%. These shifts are in the direction that generally protects against plaque buildup in arteries.
There’s an important caveat, though. Oral estrogen also raises triglyceride levels by 24 to 42%, which is a less favorable change. And the route of delivery matters: transdermal estrogen (patches) had no significant effect on cholesterol levels in the same studies. So the cholesterol benefits are specific to oral forms, and they come with trade-offs your prescriber will weigh against your individual risk factors.
Blood Clot Risk: Pills vs. Patches
One of the most important safety considerations with estrogen is its effect on blood clotting. Oral estrogen carries a 63% higher risk of venous blood clots compared to transdermal estrogen, and roughly double the risk of deep vein thrombosis specifically. There may also be a slightly increased stroke risk with oral forms.
This difference comes down to how the estrogen enters your bloodstream. Oral estrogen passes through the liver first, where it activates clotting proteins. Transdermal estrogen (patches, gels, sprays) bypasses the liver and enters the bloodstream directly through the skin, largely avoiding this effect. For people with existing clot risk factors, such as obesity, smoking, or a personal history of blood clots, the delivery method is a critical decision.
Mood and Brain Chemistry
Estrogen is deeply involved in the brain’s signaling systems. It boosts the production of serotonin, the neurotransmitter most closely linked to mood stability, by increasing the activity of the enzyme that makes it. At the same time, it dials down a serotonin receptor that acts as a brake on serotonin signaling, effectively letting more serotonin do its work.
Estrogen also influences dopamine, the neurotransmitter tied to motivation and reward, by affecting both the rate at which it’s produced and how it’s released. Additionally, it enhances glutamate release, which plays a role in learning and memory. These overlapping effects on multiple brain systems help explain why drops in estrogen during menopause or after ovary removal often bring mood changes, brain fog, and difficulty concentrating, and why estrogen therapy can improve these symptoms.
Blood Sugar and Metabolism
Premenopausal women have better insulin sensitivity and lower rates of type 2 diabetes than men of the same age. That advantage disappears after menopause, when estrogen levels fall. This isn’t a coincidence: estrogen directly improves how your cells respond to insulin and suppresses excess sugar production by the liver.
Clinical trials of estrogen replacement in postmenopausal women have shown reduced insulin resistance, lower fasting glucose, and a decreased incidence of type 2 diabetes. In animal studies that allow more precise measurement, restoring estrogen after ovary removal lowered fasting blood sugar by 21% and significantly improved glucose clearance. The mechanism works through a specific signaling chain in liver cells that estrogen activates to keep sugar production in check.
Physical Changes in Gender-Affirming Care
For transgender women and nonbinary people on feminizing hormone therapy, estrogen produces a distinct set of physical changes on a predictable timeline. Breast development typically begins 3 to 6 months after starting treatment and reaches its full effect within 2 to 3 years. Body fat redistribution, shifting toward the hips, thighs, and buttocks, follows a similar start time but can take 2 to 5 years to fully develop.
Some of these changes are reversible if estrogen is stopped, but others are not. Breast tissue, once developed, is permanent. Fat redistribution, on the other hand, will gradually shift back if hormone levels change. Skin softening, reduced body hair growth, and changes in muscle mass also occur, though the timeline varies from person to person.
Why Progesterone Is Often Paired With Estrogen
If you have a uterus, taking estrogen alone (called “unopposed estrogen”) significantly raises the risk of endometrial cancer. Five or more years of unopposed estrogen at least doubles that risk, and some studies have found risk increases of 4.5 to 8 times. With longer use, the risk can climb even higher, up to 10 to 30 times the baseline rate. This elevated risk persists for more than 10 years after stopping, even if the estrogen was only used for one year.
Adding progesterone to the regimen counteracts this effect by preventing the uterine lining from building up unchecked. This is why most prescriptions for systemic estrogen in people with a uterus include a progestogen component. People who have had a hysterectomy can safely take estrogen alone, since the organ at risk has been removed.